Sepsis - to Reduce Mortality in the Intensive Care Unit
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Sepsis - to Reduce Mortality in the Intensive Care Unit trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Sepsis - to Reduce Mortality in the Intensive Care Unit trials you may qualify forSepsis is a dysregulated host response to infection that leads to life-threatening organ dysfunction and represents a major healthcare problem. Septic shock is…
This prospective observational study aims to investigate the ability of advanced ROTEM analysis using Principal Component Analysis (PCA) to detect early signs o…
The aim of this study is to investigate if an initial short double dose of beta-lactam antibiotics will reduce mortality in critically ill patients with sepsis.
Sepsis is a life-threatening condition caused by the body's dysregulated response to an infection. While corticosteroids are known to help stabilize blood press…
Background: Sepsis is a leading cause of morbidity and mortality in intensive care units (ICUs) worldwide, accounting for millions of deaths annually. Despite…
This prospective diagnostic accuracy study evaluates the performance of presepsin and C-reactive protein (CRP) as early biomarkers for suspected sepsis in adult…